PKI-402 10mg 10mg | Purity Not Available
Adooq Bioscience
PKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier PageARQ-197 is a selective inhibitor of the c-Met receptor tyrosine kinase
More Information Supplier PageNitrisinone is a competitive inhibitor that reversibly inhibits 4-Hydroxyphenylpyruvate oxidase (dioxygenase).
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier Page